Corporate Information
About Lupin
Our Journey
Our Global Footprint
Highlights of the Year
Chairman's Letter
Vice Chairman's Letter
CEO & MD's Letter
CFO's Letter
Risk Management
Corporate Governance
Board of Directors
MD&A
India
United States
Europe, Middle East and Africa
Growth Markets
Active Pharmaceutical Ingredients
Industry Trends
Value Creation Model
Financial Capital
Manufacturing Capital
Intellectual Capital
Human Capital
Social & Relationship Capital
Natural Capital
Materiality Assessment
Reports & Financials
Ten Years Financial Summary
Directors Report
Corporate Governance Report
Business Responsibility & Sustainability Report (BRSR)
Consolidated Financial Statements
Standalone Financial Statements
Assurance Statement
Mrs. Manju D. Gupta
Chairman
Dr. Kamal K. Sharma
Vice Chairman
Ms. Vinita Gupta
Chief Executive Officer
Mr. Nilesh D. Gupta
Managing Director
Mr. Ramesh Swaminathan
Executive Director, Global CFO
& Head Corporate Affairs
Mr. Jean-Luc Belingard
Independent Director
Ms. Christine Mundkur
Independent Director
Mr. K. B. S. Anand
Independent Director
Dr. Punita Kumar-Sinha
Independent Director
Mr. Mark D. McDade
Independent Director
Audit Committee
Stakeholders' Relationship
Committee
Nomination &
Remuneration Committee
Corporate Social
Responsibility Committee
Risk Management
Committee
Committee
Members
Committee
Chairperson
Assurance Statement